OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Forecast, Price & News

$1.03

+0.03 (+3.51%)

(As of 04:15 PM ET)

Compare

Today's Range: $0.99
▼
$1.03
50-Day Range: $0.85
▼
$1.08
52-Week Range: $0.68
▼
$1.20

Volume: 5,008 shs
Average Volume: 5,218 shs
Market Capitalization: $23.67 million

P/E Ratio: 14.71
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Dividend Earnings Financials Headlines SEC Filings Short Interest

About Pharma-Bio Serv (OTCMKTS:PBSV) Stock

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in the United States and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

PBSV Price History

30 days | 90 days | 365 days | Advanced Chart

PBSV Stock News Headlines

September 18, 2023 | americanbankingnews.com

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Forecasted to Earn Q1 2024 Earnings of $0.02 Per Share

September 15, 2023 | finance.yahoo.com

PBSV Boosts Margins and Expands Markets

September 27, 2023 | Chaikin Analytics (Ad)

Fox Couldn't Air my #1 A.I. Pick - Get it Here.

50-year Wall Street Insider Marc Chaikin got invited onto Fox News to talk about A.I. - Here's what he couldn't say on television. More here.

September 14, 2023 | finance.yahoo.com

Pharma-Bio Serv Announces Results for the Three and Nine Months Ended July 31, 2023

August 31, 2023 | markets.businessinsider.com

Analysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN) and Phibro Animal Health (PAHC)

July 28, 2023 | thestreet.com

Pharma-Bio Serv Inc

July 17, 2023 | msn.com

BridgeBio Pharma: Positive ATTR-CM Treatment Data Leads To Other 2023 Catalysts

July 15, 2023 | marketwatch.com

BridgeBio Pharma Shares Rise 14% on Expected Results from Heart-Disease Study

September 27, 2023 | Behind the Markets (Ad)

66,000% upside on tiny biotech?

The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.

July 15, 2023 | marketwatch.com

Stocks to Watch: BridgeBio Pharma, Universal Security Instruments, BYND Cannasoft Enterprises

June 20, 2023 | technews.tmcnet.com

Pearl Bio Secures Breakthrough IP for Multi-Functionalized Biologics

June 15, 2023 | finance.yahoo.com

PBSV: A Consistent Performer with Impressive Dividend

June 14, 2023 | finance.yahoo.com

Pharma-Bio Serv Announces Results for the Three and Six Months Ended April 30, 2023

June 13, 2023 | ca.finance.yahoo.com

TBPMF - Tetra Bio-Pharma Inc.

June 10, 2023 | finance.yahoo.com

PBSV - Pharma-Bio Serv, Inc.

May 20, 2023 | msn.com

Avid Bioservices Bolsters Manufacturing Capabilities And Generates High-Demand Services

May 15, 2023 | tmcnet.com

BridgeBio Pharma to Present Updated Data from its

May 10, 2023 | marketwatch.com

Bio Pharma Buffer Market Research | 2023-2030

May 9, 2023 | marketwatch.com

Global "Bio Pharma Logistics Market" 2023 Research Report | Enhanced Growth Size, Estimates and Regional Outlook by 2030 | Research Reports World

April 25, 2023 | markets.businessinsider.com

Here's what Wall Street expects from Biomarin Pharmaceutical's earnings

April 20, 2023 | benzinga.com

Pharma-Bio Serv Stock (OTC:PBSV), Quotes and News Summary

April 8, 2023 | marketwatch.com

Bio Pharma Buffer Market 2023 Size and Forecast to 2031

March 20, 2023 | finance.yahoo.com

PBSV: A Steady Performer with Upside Potential

March 17, 2023 | finance.yahoo.com

Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2023

March 7, 2023 | markets.businessinsider.com

4 Analysts Have This to Say About BridgeBio Pharma

March 3, 2023 | markets.businessinsider.com

SVB Securities Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)

February 21, 2023 | marketwatch.com

Bio Pharma Buffer Market 2023: Emerging Trends and Best Practices in Futurism till 2028

See More Headlines

Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Company Calendar

Last Earnings: 9/14/2023
Today: 9/27/2023
Fiscal Year End: 10/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Management consulting services
Sub-Industry: N/A
Sector: Business Services
Current Symbol: OTCMKTS:PBSV
CUSIP: N/A
CIK: 1304161
Web: www.pharmabioserv.com
Phone: (787) 278-2709
Fax: 787-796-5168
Employees: 140
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.07
Trailing P/E Ratio: 14.71
Forward P/E Ratio: 11.44
P/E Growth: N/A
Net Income: $1.01 million
Net Margins: 8.49%
Pretax Margin: 10.91%
Return on Equity: 9.36%
Return on Assets: 7.51%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 8.05
Quick Ratio: 8.05

Sales & Book Value

Annual Sales: $19.40 million
Price / Sales: 1.22
Cash Flow: $0.05 per share
Price / Cash Flow: 22.17
Book Value: $0.70 per share
Price / Book: 1.47

Miscellaneous

Outstanding Shares: 22,980,000
Free Float: 20,226,000
Market Cap: $23.67 million
Optionable: Not Optionable
Beta: 0.41

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Victor Sanchez (Age 52)
CEO, Pres & Pres of European Operations
Comp: $298.9k

Mr. Pedro J. Lasanta (Age 63)
CFO, VP of Fin. & Admin. and Sec.
Comp: $208.6k

Ms. Elizabeth Plaza (Age 59)
Founder & Sr. Strategic Consultant

Ms. Miriam Marrero M.B.A.
HR Mang.

Key Competitors

View All Competitors

PBSV Stock - Frequently Asked Questions

How have PBSV shares performed in 2023?: Pharma-Bio Serv's stock was trading at $0.79 on January 1st, 2023. Since then, PBSV shares have increased by 30.4% and is now trading at $1.03.
View the best growth stocks for 2023 here.
Are investors shorting Pharma-Bio Serv?: Pharma-Bio Serv saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 3,300 shares, a decline of 21.4% from the August 31st total of 4,200 shares. Based on an average trading volume of 3,800 shares, the days-to-cover ratio is currently 0.9 days.
View Pharma-Bio Serv's Short Interest.
How were Pharma-Bio Serv's earnings last quarter?: Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) released its earnings results on Thursday, September, 14th. The company reported $0.02 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.02. The firm earned $4.58 million during the quarter, compared to the consensus estimate of $5.40 million. Pharma-Bio Serv had a trailing twelve-month return on equity of 9.36% and a net margin of 8.49%.
How often does Pharma-Bio Serv pay dividends? What is the dividend yield for Pharma-Bio Serv?: Pharma-Bio Serv announced a dividend on Wednesday, March 22nd. Shareholders of record on Wednesday, March 29th will be paid a dividend of $0.075 per share on Friday, April 14th. This represents a yield of 7.75%. The ex-dividend date of this dividend is Tuesday, March 28th.
Read our dividend analysis for PBSV.
What other stocks do shareholders of Pharma-Bio Serv own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma-Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Oracle (ORCL), AT&T (T), Yintech Investment (YIN), Aeglea BioTherapeutics (AGLE), Ampliphi Biosciences (APHB), Carnival Co. & (CCL) and Earthstone Energy (ESTE).

What is Pharma-Bio Serv's stock symbol?: Pharma-Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."
How do I buy shares of Pharma-Bio Serv?: Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Pharma-Bio Serv's stock price today?: One share of PBSV stock can currently be purchased for approximately $1.03.
How much money does Pharma-Bio Serv make?: Pharma-Bio Serv (OTCMKTS:PBSV) has a market capitalization of $23.67 million and generates $19.40 million in revenue each year. The company earns $1.01 million in net income (profit) each year or $0.07 on an earnings per share basis.
How many employees does Pharma-Bio Serv have?: The company employs 140 workers across the globe.
How can I contact Pharma-Bio Serv?: Pharma-Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The official website for the company is www.pharmabioserv.com. The company can be reached via phone at (787) 278-2709, via email at scottg@corprominence.com, or via fax at 787-796-5168.

This page (OTCMKTS:PBSV) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial